We speculate that transient SHIP1 inhibition in repetitive cycles can cause lytic cell death with immunogenic features in the malignant cells and simultaneously enhance the immunoresponse by directly acting on NK- and T cells to restore effective immune responses and potential anti-tumor immunity in CLL. Here, INPP5D is linked to B-cell chronic lymphocytic leukemia.